FDA Establishes Tobacco Committee
WASHINGTON -- In its implementation of the Family Smoking Prevention and Tobacco Control Act, legislation giving the U.S. Food and Drug Administration (FDA) power to regulate the tobacco industry, the organization established the Tobacco Products Scientific Advisory Committee (TPSAC).
The TPSAC will provide advice, information and recommendations to the commissioner of Food and Drugs on health and other issues relating to tobacco products, the FDA stated. The committee will also identify the effects nicotine yield alternation in tobacco products; research the impact of menthol’s use in cigarettes; and advise applications for modified risk, such as the descriptor "light," on tobacco products.
The TPSAC will consist of 12 members, including a chair who will be selected by the commissioner of Food and Drugs. There will be nine voting and three non-voting members, and of the nine voting members, seven will be health care professionals. One member will be an officer or employee of a state, local government or the federal government, and the final member will be a representative of the general public, the FDA stated.
The three non-voting members will be identified with industry interests, including one representative of the tobacco manufacturing industry, one from tobacco growers and one from the small business manufacturing industry, according to the FDA.
Related News:
FDA Names Tobacco Chief
Blazing a New Tobacco Road
The TPSAC will provide advice, information and recommendations to the commissioner of Food and Drugs on health and other issues relating to tobacco products, the FDA stated. The committee will also identify the effects nicotine yield alternation in tobacco products; research the impact of menthol’s use in cigarettes; and advise applications for modified risk, such as the descriptor "light," on tobacco products.
The TPSAC will consist of 12 members, including a chair who will be selected by the commissioner of Food and Drugs. There will be nine voting and three non-voting members, and of the nine voting members, seven will be health care professionals. One member will be an officer or employee of a state, local government or the federal government, and the final member will be a representative of the general public, the FDA stated.
The three non-voting members will be identified with industry interests, including one representative of the tobacco manufacturing industry, one from tobacco growers and one from the small business manufacturing industry, according to the FDA.
Related News:
FDA Names Tobacco Chief
Blazing a New Tobacco Road